NUCLEAR SHAPE AS A PROGNOSTIC DISCRIMINANT IN COLORECTAL-CARCINOMA

被引:37
作者
MITMAKER, B
BEGIN, LR
GORDON, PH
机构
[1] SIR MORTIMER B DAVIS JEWISH HOSP,DEPT PATHOL,MONTREAL H3T 1E2,QUEBEC,CANADA
[2] MCGILL UNIV,MONTREAL H3A 2T5,QUEBEC,CANADA
关键词
NUCLEAR SHAPE; PROGNOSTIC DISCRIMINANT; COLORECTAL CARCINOMA; IMAGE ANALYSIS;
D O I
10.1007/BF02090165
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
In search for a more reliable prognostic discriminant, a retrospective analysis of 100 cases of colorectal carcinoma having undergone curative resection and followed for at least 5 years were assessed by nuclear morphometry. Each case was staged according to the Dukes' classification as well as graded histologically. For all patients in this series, the perimeter, area, and nuclear shape factor of 50 interphase nuclei were determined for each carcinoma. The information was obtained through the use of an image analysis system by tracing the nuclear profiles (magnification 1000x) as digitized on a video screen. The nuclear shape factor was defined as the degree of circularity of the nucleus, a perfect circle recorded as 1.0. A nuclear shape factor greater than 0.84 was associated with poor outcome. Multiple regression models showed that the single nuclear parameter of the shape factor was the most highly significant predictor of survival (P < 0.0001). This variable remained highly significant even when corrected for sex, age, histologic grade, and Dukes' classification. These findings indicate that a nuclear shape factor greater-than-or-equal-to 0.84 as determined by nuclear morphometry is an independent morphometric nuclear variable of great importance in the prognosis of large bowel carcinoma.
引用
收藏
页码:249 / 259
页数:11
相关论文
共 53 条
[1]   HISTOPATHOLOGIC EVALUATION OF SURVIVAL-TIME IN PATIENTS WITH COLORECTAL-CARCINOMA [J].
ADACHI, Y ;
MORI, M ;
KUROIWA, S ;
SUGIMACHI, K ;
ENJOJI, M .
JOURNAL OF SURGICAL ONCOLOGY, 1989, 42 (04) :219-224
[2]   THE INFLUENCE OF TUMOR-CELL DNA ABNORMALITIES ON SURVIVAL IN COLORECTAL-CANCER [J].
ARMITAGE, NC ;
ROBINS, RA ;
EVANS, DF ;
TURNER, DR ;
BALDWIN, RW ;
HARDCASTLE, JD .
BRITISH JOURNAL OF SURGERY, 1985, 72 (10) :828-830
[3]  
BAAK JPA, 1985, CANCER, V56, P374, DOI 10.1002/1097-0142(19850715)56:2<374::AID-CNCR2820560229>3.0.CO
[4]  
2-9
[5]   MORPHOMETRIC DATA TO FIGO STAGE AND HISTOLOGICAL TYPE AND GRADE FOR PROGNOSIS OF OVARIAN-TUMORS [J].
BAAK, JPA ;
WISSEBREKELMANS, ECM ;
LANGLEY, FA ;
TALERMAN, A ;
DELEMARRE, JFM .
JOURNAL OF CLINICAL PATHOLOGY, 1986, 39 (12) :1340-1346
[6]   DISCRIMINATION OF HYPERPLASIA AND CARCINOMA OF THE ENDOMETRIUM BY QUANTITATIVE MICROSCOPY - A FEASIBILITY STUDY [J].
BAAK, JPA ;
KURVER, PHJ ;
DIEGENBACH, PC ;
DELEMARRE, JFM ;
BREKELMANS, ECM ;
NIEUWLAAT, JE .
HISTOPATHOLOGY, 1981, 5 (01) :61-68
[7]  
BAUER KD, 1987, LAB INVEST, V57, P329
[8]   DYNAMIC ASSOCIATION OF REPLICATING DNA FRAGMENTS WITH THE NUCLEAR MATRIX OF REGENERATING LIVER [J].
BEREZNEY, R ;
BUCHHOLTZ, LA .
EXPERIMENTAL CELL RESEARCH, 1981, 132 (01) :1-13
[9]  
BIBBO M, 1990, CANCER RES, V50, P147